Cardiovascular disease (CVD) is the leading global cause of death, accounting for 17.3
million deaths per year. Preventive treatment that reduces CVD by even a small percentage …

Previous interest in high-density lipoproteins (HDLs) focused on their possible protective
role in atherosclerotic cardiovascular disease (ASCVD). Evidence from genetic studies and …

Background The relationship between macronutrients and cardiovascular disease and
mortality is controversial. Most available data are from European and North American …

The increasing prevalence of diabetes and its complications, such as cardiovascular and
kidney disease, remains a huge burden globally. Identification of biomarkers for the …

Background: Blood lipids are established risk factors for myocardial infarction (MI), but
uncertainty persists about the relevance of lipids, lipoprotein particles, and circulating …

Context The value of assessing various emerging lipid-related markers for prediction of first
cardiovascular events is debated. Objective To determine whether adding information on …

Pandemic obesity is a major public health problem because of its association with non-
communicable diseases and all-cause mortality, which can be improved/delayed with …

Several prospective epidemiological studies have shown that there is a clear inverse
relationship between serum high-density lipoprotein-cholesterol (HDL-C) concentrations …

Since the discovery in the 1970s that plasma levels of high-density lipoprotein cholesterol
(HDL-C) are inversely associated with cardiovascular outcome, it has been postulated that …

Cardiovascular diseases are the worldwide leading cause of mortality. Cardiovascular
diseases are noncommunicable conditions with a complex pathogenesis, and their clinical …